OPEN END-TURBO-OPTIONSSCHEIN - DEXCOM Stock

DE000TT67J49

Market Closed - BOERSE MUENCHEN 03:37:41 2024-07-15 pm EDT
1.38 ^EUR	-4.83%

Current month	-0.72%
1 month	-9.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Chart OPEN END-TURBO-OPTIONSSCHEIN - DEXCOM

Latest news about DEXCOM, INC.

Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating	Jul. 15	MT
Stifel Adjusts Price Target on DexCom to $132 From $145	Jul. 12	MT
UPC Issues Two First Instance Decisions On Infringement	Jul. 11	AQ
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10

More news

Quotes 5-day view

Date	Price	Change
24-07-15	1.38	-4.83%
24-07-12	1.45	+4.32%
24-07-11	1.39	+5.30%
24-07-10	1.32	-0.75%
24-07-09	1.33	0.00%

Real-time BOERSE MUENCHEN

Last update July 15, 2024 at 03:37 pm EDT

More quotes

Static data

Product type	Knock-Out ohne Stop Loss
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	HSBC
WKN	TT67J4
ISIN	DE000TT67J49
Date issued	2021-05-06
Strike	75.67 $
Maturity	Unlimited
Parity	25 : 1
Emission price	1.2 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	3.67 €
Lowest since issue	0.2 €

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

113 USD

Average target price

149.3 USD

Spread / Average Target

+32.11%

Consensus